12:00 AM
 | 
Mar 29, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

DuoPlavin/ DuoCover clopidogrel/acetylsalicylic acid regulatory update

The European Commission approved an MAA from Bristol-Myers for DuoPlavin/DuoCover to prevent atherothrombotic events in adults already taking

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >